Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing-Reference-Cited by-同舟云学术

Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing

Published:2022-07-15 Issue:9 Volume:101 Page:1987-2000
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Maddali Madhavi,Venkatraman Arvind,Kulkarni Uday Prakash,Mani Sathya,Raj Santhosh,Sigamani Elanthenral,Korula Anu,A Fouzia N,Lionel Sharon Anbumalar,Selvarajan Sushil,Manipadam Marie Therese,Abraham Aby,George Biju,Mathews Vikram,Balasubramanian Poonkuzhali^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-022-04920-w.pdf

Reference42 articles.

1. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al (2014) CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28(7):1472–1477

2. Langabeer SE (2016) Chasing down the triple-negative myeloproliferative neoplasms: implications for molecular diagnostics. JAK-STAT 5(2–4):e1248011

3. Milosevic Feenstra JD, Nivarthi H, Gisslinger H, Leroy E, Rumi E, Chachoua I et al (2016) Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood 127(3):325–332

4. Diaconnu C, Mambet C, Necula L, Gurban P, Matei L, Aldea-Pitica I et al (2017) Triple negative myeloproliferative neoplasms - sometimes driver mutations stay low-key in plain sight. Roman Biotechnol Lett 23(4). https://doi.org/10.26327/RBL2017.12

5. McClure RF, Ewalt MD, Crow J, Temple-Smolkin RL, Pullambhatla M, Sargent R et al (2018) Clinical significance of DNA variants in chronic myeloid neoplasms: a report of the association for molecular pathology. J Mol Diagn 20(6):717–737

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths;Cell Biochemistry and Biophysics;2024-06-07

2. Emerging drug profile: JAK inhibitors;Leukemia & Lymphoma;2024-05-13

3. Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine;Cancers;2024-04-26

4. The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective;Leukemia Research;2024-01

5. BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing;Frontiers in Genetics;2023-09-08